Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Lucid Diagnostics Inc LUCD

Healthcare Medical Devices
Lucid Diagnostics Inc. is a commercial-stage medical diagnostics technology company. The Company is focused on patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux or simply reflux, that leads to esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma (EAC). The Company’s products include EsoGuard, and EsoCheck. EsoGuard is a... see more

Recent & Breaking News (NDAQ:LUCD)

PAVmed Provides Business Update and Second Quarter Financial Results

PR Newswire August 15, 2023

Lucid Diagnostics Provides Business Update and Second Quarter Financial Results

PR Newswire August 14, 2023

PAVmed to Hold a Business Update Conference Call and Webcast on August 16, 2023

PR Newswire July 31, 2023

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on August 15, 2023

PR Newswire July 31, 2023

Lucid Diagnostics to Present at the Canaccord Genuity 43rd Annual Growth Conference

PR Newswire July 26, 2023

PAVmed and Lucid Chairman and Chief Executive Officer, Dr. Lishan Aklog, Testifies at U.S. House of Representatives Energy and Commerce Committee, Hearing on Life-Saving Innovations and Medicare Coverage

PR Newswire July 19, 2023

PAVmed Receives 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Requirement

PR Newswire June 28, 2023

PAVmed to Participate in Healthcare Virtual Conference Presented by Maxim Group LLC

PR Newswire June 14, 2023

Lucid Diagnostics Launches First EsoGuard® Mobile Test Unit

PR Newswire June 5, 2023

PAVmed Digital Health Subsidiary, Veris Health, Joins Cancer Moonshot's CancerX Partnership as Founding Member

PR Newswire June 2, 2023

PAVmed Provides Business Update and First Quarter Financial Results

PR Newswire May 16, 2023

Lucid Diagnostics Provides Business Update and First Quarter Financial Results

PR Newswire May 15, 2023

Lucid Diagnostics and Collaborators Present New EsoGuard® and EsoCheck® Data at Digestive Disease Week® (DDW) 2023 Conference

PR Newswire May 11, 2023

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 16, 2023

PR Newswire May 5, 2023

PAVmed to Hold a Business Update Conference Call and Webcast on May 17, 2023

PR Newswire May 5, 2023

PAVmed Digital Health Subsidiary, Veris Health, Appoints Gary Manning as President

PR Newswire April 25, 2023

PAVmed Digital Health Subsidiary, Veris Health, to Present Comprehensive Meta-analysis on Impact of Remote Patient Monitoring in Oncology at HIMSS

PR Newswire April 19, 2023

Lucid Diagnostics Reports Publication of Future Effective Foundational Local Coverage Determination by Medicare Administrative Contractor Noridian Healthcare Solutions

PR Newswire April 18, 2023

Lucid Diagnostics to Present at 22nd Annual Needham Virtual Healthcare Conference

PR Newswire April 17, 2023

Lucid Diagnostics Provides Update on Newly Published Future Effective Medicare Local Coverage Determination on Molecular Testing for Detection of Esophageal Precancer and Cancer

PR Newswire March 31, 2023